Home slider beeld 02
Lab website TS Essen.jpg
myeuniter_gruppenfoto-8234_beschriftet borderless web.jpg

    In cancer, infection and inflammation, the immune system’s function is dysregulated, contributing to disease pathology. As part of this process, instead of fighting disease, immune cells may even suppress beneficial immune responses and increase pathology. Despite their pathophysiological importance, the identity and biology of the so called myeloid regulatory cells (MRCs) is poorly understood. 


    European Network of Investigators Triggering Exploratory Research on Myeloid Regulatory Cells


    Action Chair: Sven Brandau (DE)

    Vice-Chair: Annabel Valledor (ES)

    News and Events
    There is no news at the moment

    Europe's largest network investigating MRC's. APPLY


    The COST Action Mye-EUNITER is proud to announce the first four publications of a Symposium-in-Writing in Cancer Immunology Immunotherapy which has been written by its members:

    MDSCs in infectious diseases: regulation, roles, and readjustment. Dorhoi A, Glaría E, Garcia-Tellez T, Nieuwenhuizen NE, Zelinskyy G, Favier B, Singh A, Ehrchen J, Gujer C, Münz C, Saraiva M, Sohrabi Y, Sousa AE, Delputte P, Müller-Trutwin M, Valledor AF. Cancer Immunol Immunother. 2018 Dec 19. doi: 10.1007/s00262-018-2277-y

    Role of myeloid regulatory cells (MRCs) in maintaining tissue homeostasis and promoting tolerance in autoimmunity, inflammatory disease and transplantation. Amodio G, Cichy J, Conde P, Matteoli G, Moreau A, Ochando J, Oral BH, Pekarova M, Ryan EJ, Roth J, Sohrabi Y, Cuturi MC, Gregori S. Cancer Immunol Immunother. 2018 Oct 24. doi: 10.1007/s00262-018-2264-3.

    Interactions among myeloid regulatory cells in cancer. Umansky V, Adema GJ, Baran 4, Brandau S, Van Ginderachter JA, Hu X, Jablonska J, Mojsilovic S, Papadaki HA, Pico de Coaña Y, Santegoets KCM, Santibanez JF, Serre K, Si Y, Sieminska I, Velegraki M, Fridlender ZG. Cancer Immunol Immunother. 2018 Jul 12. doi: 10.1007/s00262-018-2200-6.

    How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions. Bruger AM, Dorhoi A, Esendagli G, Barczyk-Kahlert K, van der Bruggen P, Lipoldova M, Perecko T, Santibanez J, Saraiva M, Van Ginderachter JA, Brandau S. Cancer Immunol Immunother. 2018 May 21. doi: 10.1007/s00262-018-2170-8

    © Springer-Verlag GmbH Germany, part of Springer Nature 2018

    Cancer II.jpg